The neuroendocrine system and rheumatoid arthritis: insights from anti-tumor necrosis factor-alpha therapy.
Sternberg
Esther M
EM
Silverman
Marni N
MN
Cizza
Giovanni
G
D000302:Adrenal Cortex / Q000187:drug effects / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D015415:Biomarkers / Q000378:metabolism; D003687:Dehydroepiandrosterone / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000503:physiopathology; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D003687:Dehydroepiandrosterone